Effect of Inhaled Magnesium Sulphate on Bronchodilating Response, Levels of Substance P and Clinical Improvement of Acute Exacerbations COPD Patients
DOI:
https://doi.org/10.36497/jri.v38i1.135Keywords:
MgSO4 inhalation, substance P, acute exacerbation of COPDAbstract
Background: Inhaled magnesium sulphate has a bronchodilator and antiinflammatory effect by block the calcium channels and inhibiting substance P. This study aimed to analyze the effect of magnesium sulfate inhalation on bronchodilator response, substance P levels, and clinical improvement on AECOPD patients. Methods: A quasi-experimental clinical trial, pre-test and post-test design with 34 acute exacerbation of COPD patients who are hospitalized in emergency room on Dr. Moewardi Hospital, Surakarta and Ario Wirawan Hospital, Salatiga on March-April 2017 used consecutive sampling. The independent variable is inhaled magnesium sulphate dose of 150 mg 3 times every 20 minutes when the patients was admitted in emergency room, while the dependent variables are peak expiratory flow rate, the plasma levels of substance P and CAT score acute exacerbation of COPD patients. Results: There was a significant difference (P=0.009) decrease of PEFR value of treatment group (111.76±12.37) compared to control group (141.18±24.21). There was a significant difference (P=0.0001) decrease in CAT score of treatment group (-14.88±1.75) compared to control group (-9.00±1.17). There was a significant difference (P=0.0001) treatment group (-1305.92±417.91) than control group (-355.95±206.25). Conclucions: The addition of MgSO4 inhalation of 150 mg during exacerbation increased PEFR, decreased the level of P substance, and decreased the CAT score with statistically significant results. (J Respir Indo 2018; 38(1): 16-23)Downloads
References
Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2017 Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2017 (accessed 2 May 2017).
Amin M, Yunus F, Antariksa B, Djajalaksana S, Wiyono WH, Sutoyo DK, et al. Dalam: Amin M, editor. Penyakit Paru Obstruktif Kronik. Jakarta: Universitas Indonesia; 2016. p.8-49.
Brashier BB, Kodgule R. Risk factors and pathophysiology of chronic obstructive pulmonary disease (COPD). J Assoc Physicians India. 2012;60:17-21.
Barnes PJ, Cosio MG. Cells and mediators of chronic obstructive pulmonary disease. Eur Respir Mon. 2006;38:130-58.
Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J. 2007;29:1224-38.
Pothirat C, Chaiwong W, Phetsuk N, Liwsrisakun C, Bumroongkit C, Deesomchok A, et al. Peak expiratory flow rate as a surrogate for forced expiratory volume in 1 second in COPD severity classification in Thailand. Int J Chron Obstruct Pulmon Dis. 2015;10:1213.
Webb RC. Smooth muscle contraction and relaxation. Advances in physiology education. 2003;27:201-6.
O'Connor TM, O'Connell J, O'Brien DI, Goode T, Bredin CP, Shanahan F. The role of substance P in inflammatory disease. J Cellular Physiol. 2004;201:167-80.
Wisnuwardhani D. Hiperreaktivitas bronkus pada penyakit paru obstrukstif kronik. Cermin Dunia Kedokteran, 2013;40:579-84.
Tu YH, Zhang Y, Fei GH. Utility of the CAT in the therapy assessment of COPD exacerbations in China. BMC Pulm Med. 2014;14:42.
Soetedjo FA, Margono BP. Peran antikolinergik sebagai bronkodilator. Majalah Kedokteran Respirasi. 2011;2:12.
Akhtar MI, Ullah H, Hamid M. Magnesium, a drug of diverse use. J Pak Med Assoc. 2011;61:1220.
De Baaij JH, Hoenderop JG, Bindels RJ. Magnesium in man: implications for health and disease. Physiol Rev. 2015;95:1-46.
Yulistiana F, Suradi, Reviono, Sutanto YS, Raharjo AF, Makhabah DN. Pengaruh vitamin C terhadap kadar interleukin 6 plasma, MDA plasma, dan lama rawat inap penderita PPOK eksaserbasi. J Respir Indo. 2016;36:157-66.
Coates AL, Leung K, Vecellio L, Schuh S. Testing of nebulizers for delivering magnesium sulfate to pediatric asthma patients in the emergency department. Respir Care. 2011;56:314-8.
Emerman CL, Cydulka RK. Use of expiratory flow rate in emergency department evaluation of acute exacerbation of chronic obstructive pulmonary disease. Annals of Emergency Medicine 1996; 27:159-63.
Bhatt SP, Khandelwal P, Nanda S, Stoltzfus JC, Fioravanti GT. Serum magnesium is an independent predictor of frequent readmissions due to acute exacerbation of chronic obstructive pulmonary disease. Respir Med. 2008;102:999-1003.
Edwards L, Shirtcliffe P, Wadsworth K, Healy B, Jefferies S, Weatherall M, et al. Use of nebulised magnesium sulphate as an adjuvant in the treatment of acute exacerbations of COPD in adults a randomised double blind placebo controlled trial. Thorax. 2013;6:1-6.
Comert S. Role of magnesium sulphate in exacerbations of chronic obstructive pulmonary disease. Journal of Respiratory Research. 2015;1:10-2.
Emerman CL, Cydulka RK. Use of expiratory flow rate in emergency department evaluation of acute exacerbation of chronic obstructive pulmonary disease. Annals of Emergency Medicine 1996; 27:159-63.
Silajiya D, Modi U, Varlekar N, Vyas NJ. Immediate effect of magnesium sulphate nebulization in post operative cardiac patients with COPD. Internationale Journal of Therapies and Rehabiliotation Research. 2016;5:52-4.
Downloads
Additional Files
Published
Issue
Section
License
- The authors own the copyright of published articles. Nevertheless, Jurnal Respirologi Indonesia has the first-to-publish license for the publication material.
- Jurnal Respirologi Indonesia has the right to archive, change the format and republish published articles by presenting the authors’ names.
- Articles are published electronically for open access and online for educational, research, and archiving purposes. Jurnal Respirologi Indonesia is not responsible for any copyright issues that might emerge from using any article except for the previous three purposes.
